Tacrolimus treatment of steroid-resistant rejection provides economic advantages compared with OKT3 therapy.
Tacrolimus treatment of steroid-resistant rejection provides economic advantages compared with OKT3 therapy. Transplant Proc. 1997 Feb-Mar; 29(1-2):1549.